Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
Public ClinicalTrials.gov record NCT00801931. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Double Umbilical Cord Blood Transplantation for Patients With Malignant and Non-Malignant Disorders
Study identification
- NCT ID
- NCT00801931
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Columbia University
- Other
- Enrollment
- 1 participant
Conditions and interventions
Conditions
Interventions
- Alemtuzumab Drug
- Busulfan Drug
- Cyclophosphamide Drug
- Fludarabine Drug
- Horse Antithymocyte Globulin Drug
- Melphalan Drug
- Phenytoin Drug
- Rabbit Antithymocyte Globulin Drug
- Thiotepa Drug
- Total Body Irradiation Radiation
Drug · Radiation
Eligibility (public fields only)
- Age range
- Up to 30 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 5, 2007
- Primary completion
- May 4, 2009
- Completion
- May 4, 2009
- Last update posted
- Mar 26, 2019
2007 – 2009
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Columbia Presbyterian Medical Center | New York | New York | 10032 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00801931, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 26, 2019 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00801931 live on ClinicalTrials.gov.